December 2, 2020 – Ortho Clinical Diagnostics (Raritan, NJ) announced the CE Mark availability of its semi-automated ORTHO Optix Reader, which the company says will allow lower-volume transfusion labs to elevate their standard of patient care with the quality of results expected from an automated platform.
The ORTHO Optix Reader’s high-resolution camera captures color, grayscale, front and back images of each test without operator intervention, which provides objective data for automated results interpretation and eliminates the subjectivity and discrepancies of multiple operators reviewing images by eye.
When paired with the ORTHO Workstation, the ORTHO Optix Reader provides a complete semi-automated testing platform for transfusion labs with low- to mid-volume throughput. Because the ORTHO Optix Reader has been shown to deliver 99.9% concordance with the fully automated ORTHO VISION Analyzer, it also offers larger volume labs and healthcare networks a way to back-up or scale up their operations without having to invest in an additional full-automation analyzer. The concordant and high-resolution images of the ORTHO Optix Reader also help to support the technologist during remote review of results from across the laboratory.
Just like the ORTHO VISION Analyzer, the ORTHO Optix Reader leverages Ortho’s comprehensive testing menu, including antibody panels, selected cells and dilution series.
The ORTHO Optix Reader is supported by Ortho Care, Ortho’s award-winning, holistic service and support solution, and is now available in countries that accept CE Mark.